Boston Scientific Lays Out Near-Term Growth Plan
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific’s ongoing effort to reorganize and recharge its product pipeline and reduce manufacturing costs will restore higher revenue growth over the next few years, executives said during a Nov. 19 day-long investor presentation.